CSID APP Leadership Summits - A CME Proceedings Newsletter for Advanced Practice Providers

To claim 1.0 credit for this activity, please visit:

Release date: March 1, 2024

Expiration date: March 1, 2025

(Download includes CME accreditation material)

Target Audience

The joint providership estimates the initiative will attract an audience of 5,000 participants, including physicians, nurse practitioners, nurses, and physician assistants. A comprehensive reach optimization effort will be driven by the Gi Health Foundation (GiHF) and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) proprietary databases and educational portals. Outreach will focus on health care professionals who have opted-in for educational updates from GiHF and GHAPP.

The joint providership of Medical Education Resources (MER) and GiHF proposes to develop an accredited proceedings e-Newsletter on the management of patients with CSID. In addition to the content discussed during the CSID leadership summits and virtual mentorship sessions, additional expert opinions, recent publications, abstracts, and presentations from congress meetings will be reviewed as part of the e-Newsletter development process. The e-Newsletter will launch in February 2024 and reach more than 5,000 participants via GiHF’s and GHAPP’s educational portals and will be posted for a period of at least 12 months.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Describe the prevalence of CSID in patients with common GI disorders
  • Incorporate current diagnostic strategies to differentiate CSID from other causes of persistent diarrhea seen in clinical practice, particularly among patients with suspected IBS
  • Summarize benefits and limitations of current treatment strategies for CSID

Faculty and Planners

Patrick Horne, NP
Daksesh Patel, DO
Brooks Cash, MD
Lavanya Viswanathan, MD, MS, FACP
Moriane Joseph, NP
Kate Scarlata, MPH, RDN
Julie Messick, PharmD

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and GiHF. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit

Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Medical Education Resources designates this live activity for a maximum of 1.0 ANCC nursing contact hour. Nurses will be awarded contact hours upon successful completion of the activity.

Physician Assistant Credit

Medical Education Resources has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME Credits. Physician Assistants should only claim credit commensurate with the extent of their participation.

Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Chronic Liver Disease Foundation, and/or QOL Medical LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Fee Information

There is no fee for this educational activity.

This activity is jointly provided by Medical Education Resources and the Gi Health Foundation.

Supported by educational grant from QOL Medical LLC.